DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tasigna (Nilotinib) - News


News related to Tasigna (Nilotinib) and/or conditions it is approved for

TKIs associated with increased risk for cardiovascular events in patients with chronic myeloid leukemia
Source: Cardiovascular / Cardiology News From Medical News Today [2016.06.14]
Patients taking tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) face an increased risk for arterial and venous vascular events.

Texan is first adult in U.S. to receive updated stem cell transplant for leukemia treatment
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.06.14]
Texan Chuck Dandridge became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member, announced researchers at...

Antibody-based drug helps 'bridge' leukemia patients to curative treatment
Source: Cancer / Oncology News From Medical News Today [2016.06.13]
Study reports complete cancer remission rate higher than conventional chemotherapy for acute lymphoblastic leukemia.

The root of evil: Pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence
Source: Cancer / Oncology News From Medical News Today [2016.06.13]
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. Treatment with intensive chemotherapy often leads to a period of freedom from overt disease called a remission.

Putting a brake on leukemia cells
Source: Cancer / Oncology News From Medical News Today [2016.06.10]
Biomarkers play an important role in modern cancer medicine. They are used as tools to diagnose cancers more precisely and to better predict the course of the disease.

Acute myeloid leukemia has at least 11 different subtypes
Source: Cancer / Oncology News From Medical News Today [2016.06.09]
A landmark study has uncovered at least 11 different subtypes of acute myeloid leukemia, each with unique genetic alterations and clinical features.

Study provides new clues to leukemia resurgence after chemotherapy
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.06.03]
Findings may lead to new strategies to fight drug resistance in acute myeloid leukemia; findings may also shed light on other cancer types.

Two-pronged attack on chemotherapy-resistant leukemia cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.05.19]
All stems from malignant transformed precursor lymphocytes, the blood's defense cells. Nowadays, four out of five young leukemia patients can be treated successfully with aggressive chemotherapy.

Study: 93 percent of advanced leukemia patients in remission after immunotherapy
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.28]
'Extraordinary' but short-term results from early-stage trial of engineered immune cells.

Source: MedicineNet Carpal Tunnel Syndrome Specialty [2016.02.03]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/3/2016 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Blinatumomab Beats Chemo for R/R ALL: Survival Doubled
Source: Medscape Hematology-Oncology Headlines [2016.06.16]
The single-agent immunotherapy was superior to chemotherapy in relapsed/refractory acute lymphoblastic leukemia, almost doubling overall survival in the phase 3 TOWER trial.
Medscape Medical News

CAR T-cell Therapy: Getting a Handle on Toxicity
Source: Medscape Hematology-Oncology Headlines [2016.06.14]
Chimeric antigen receptor (CAR) T-cell therapies have some dramatic results in leukemia and lymphoma, but treatment toxicity needs careful handling.
Medscape Medical News

AML Recurrence Linked to Persistent Preleukemic Clones
Source: Medscape Hematology-Oncology Headlines [2016.06.13]
For the first time, a study shows that even when acute myeloid leukemia is pushed into remission by chemotherapy, some persistent preleukemic clones may be linked to shortened survival.
Medscape Medical News

Methotrexate exposure impacts cognitive processes cancer survivors need to multitask
Source: Cancer / Oncology News From Medical News Today [2016.06.07]
Research from St. Jude Children's Research Hospital suggests that pediatric leukemia patients exposed to higher concentrations of the chemotherapy drug methotrexate are more likely to struggle with...

Study links residential radon exposure to hematologic cancers in women
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.29]
A new report finds a statistically-significant, positive association between high levels of residential radon and the risk of hematologic cancer (lymphoma, myeloma, and leukemia) in women.

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015